In vivo imaging of the cannabinoid CB1 receptor with positron emission tomography

E-ISSN： 1532-6535|97|6|565-567

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.6, 2015-06, pp. : 565-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1507-1511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positron Emission Tomography Imaging of Tumor Hypoxia

Current Medical Imaging Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 8-16

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 20, 2015-10 ,pp. : 4790-4805

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preclinical Imaging of Mammary Intraepithelial Neoplasia with Positron Emission Tomography

By Abbey Craig Borowsky Alexander Gregg Jeffery Cardiff Robert Cherry Simon

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 2, 2006-04 ,pp. : 137-149

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Different Techniques for Stereotactic Positron Emission Tomography Imaging

Stereotactic and Functional Neurosurgery, Vol. 86, Iss. 1, 2007-09 ,pp. : 30-36

Karger

Access to resources Recommend Favorite